MCP
MRNA icon

Militia Capital Partners’s Moderna MRNA Stock Holding History

Militia Capital Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$73.7K Buy
+19,400
New +$527K 0.03% 184
2025
Q3 		– Sell
-37,400
Closed -$87.5K – 207
2025
Q2 		$87.5K Sell
37,400
-1,900
-5% -$50K 0.04% 166
2025
Q1 		$17.6K Buy
+39,300
New +$1.39M 0.01% 134

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Militia Capital Partners's MRNA Position: Q4 2025 in Review

Militia Capital Partners increased its Moderna (MRNA) stake by 113% in Q4 2025, buying an estimated $427K and bringing the position to 29,601 shares worth $873K. The position accounts for 0.33% of the portfolio, ranked #98.

Militia Capital Partners first reported a position in MRNA in Q1 2025 and has held it in 4 quarters since. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Militia Capital Partners held 29,601 shares of Moderna worth $873K as of Q4 2025.
  • Militia Capital Partners bought 15,717 Moderna shares in Q4 2025, an estimated $427K.
  • Moderna made up 0.33% of Militia Capital Partners's portfolio in Q4 2025, its #98 holding.
  • Militia Capital Partners first reported a position in Moderna in Q1 2025 and has held it in 4 quarters since.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.